about
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotypePrognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinomaEffects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.Single nucleotide polymorphism (SNP) analysis used for the phylogeny of the Mycobacterium tuberculosis complex based on a pyrosequencing assay.CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells.Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.Altered gene expression in human placenta after suspected preterm labour.TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases.Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotypeGastric Cancer Susceptibility Is Not Linked to Pro-and Anti-Inflammatory Cytokine Gene Polymorphisms in Whites: A Nationwide Multicenter Study in SpainTGFB1 gene polymorphisms and inflammatory bowel diseaseA new BRCA1 mutation in a Filipino woman with a family history of breast and ovarian cancerAssociation between achalasia and nitric oxide synthase gene polymorphismsGenomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancerRelevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production
P50
Q33829340-E07CC49A-EE8D-45C2-BF15-26571F7C1E26Q34430932-2E052C8E-73D4-49E9-B0C8-9910F5C29CEDQ40211934-2122A22F-B596-41D2-A9EA-43B39B674E85Q41461702-B1EDA26F-7E33-41DB-9C0C-7127F93C993BQ41951115-D347E2A2-CA42-494B-A464-C917F2690E99Q42240172-AD494746-BC9E-439D-8DAB-B8E36502661DQ42642935-856AB48F-D865-415E-89FE-CDFECB0AC05DQ50204795-FA970F57-67FC-4DD4-B416-CCA0094681EDQ54581283-6320B369-090C-40A4-BD7E-51B959CE8381Q57942535-EF9C8E4E-83E0-4849-9239-E05445760807Q57942571-76E090F9-013A-44FE-91D2-03077CA1A202Q74257013-D56FB399-4DA3-4BC1-B947-46EA87EAA608Q77626786-73BC53E2-F3BE-47DD-938B-9D065F2C3842Q79927634-79A263CE-149B-49C2-A93E-F1A8654C06A2Q80347093-C2037841-6015-40BE-BE48-988FE59D6193Q84372231-D6C2D961-D92F-4FFE-A85E-1E345D8AE5EB
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-8619-3979
@en
name
Mark Strunk
@ast
Mark Strunk
@en
Mark Strunk
@es
Mark Strunk
@nl
type
label
Mark Strunk
@ast
Mark Strunk
@en
Mark Strunk
@es
Mark Strunk
@nl
prefLabel
Mark Strunk
@ast
Mark Strunk
@en
Mark Strunk
@es
Mark Strunk
@nl
P106
P21
P31
P496
0000-0002-8619-3979